ScholarIQanswers from OpenAlex & ORCID
Roser Torrá
ResearcherPublications, citations & collaboration network
Roser Torrá is a researcher indexed in ScholarIQ from OpenAlex & ORCID.
How many works does Roser Torrá have?
ScholarIQindexed works
Roser Torrá has 318 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does Roser Torrá have?
ScholarIQcitation count
Roser Torrá has 12,277 citations in the OpenAlex counts ScholarIQ stores.
What is the h-index of Roser Torrá?
ScholarIQh-index
Roser Torrá has an h-index of 57 in OpenAlex.
What is the i10-index of Roser Torrá?
ScholarIQi10-index
Roser Torrá has an i10-index of 156 in OpenAlex.
What is the ORCID of Roser Torrá?
ScholarIQorcid
The ORCID for Roser Torrá is on the source record.
What is the OpenAlex record for Roser Torrá?
ScholarIQopenalex
The OpenAlex for Roser Torrá is on the source record.
What are the most-cited papers on Roser Torrá?
ScholarIQmost cited works
Unified Criteria for Ultrasonographic Diagnosis of ADPKD
York Pei, James Obaji, Annie Dupuis, Andrew D. Paterson, Riccardo Magistroni, Elizabeth Dicks, Patrick S. Parfrey, B. Cramer, Eliécer Coto, Roser Torrá, José L. San Millán, Robert N. Gibson, Martijn H. Breuning, Dorien J.M. Peters, David Ravine
Comparison of phenotypes of polycystic kidney disease types 1 and 2
Nick Hateboer, Marjan A. van Dijk, Nadja Bogdanova, Eliécer Coto, Anand K Saggar‐Malik, J L San Millán, Roser Torrá, Martijn H. Breuning, David Ravine
Autosomal-dominant polycystic kidney disease (ADPKD): executive summary from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference
Arlene B. Chapman, Olivier Devuyst, Kai‐Uwe Eckardt, Ron T. Gansevoort, Tess Harris, Shigeo Horie, Bertram L. Kasiske, Dwight Odland, York Pei, Ronald D. Perrone, Yves Pirson, Robert W. Schrier, Roser Torrá, Vicente E. Torres, Terry Watnick, David C. Wheeler
Treatment of Fabry’s Disease with the Pharmacologic Chaperone Migalastat
Dominique P. Germain, Derralynn Hughes, Kathy Nicholls, Daniel G. Bichet, Roberto Giugliani, William R. Wilcox, Claudio Feliciani, Suma P. Shankar, Fatih Süheyl Ezgü, Hernan Amartino, Drago Bratkovic, Ulla Feldt‐Rasmussen, Khan Nedd, Usama Sharaf El Din, Charles Marques Lourenço, Maryam Banikazemi, Joel Charrow, Majed Dasouki, David N. Finegold, Pilar Giraldo, Özlem Göker-Alpan, Nicola Longo, C. Ronald Scott, Roser Torrá, Ahmad Tuffaha, Ana Jovanović, Stephen Waldek, Seymour Packman, Elizabeth Ludington, Christopher Viereck, John Kirk, Julie Yu, Elfrida R. Benjamin, Franklin K. Johnson, David J. Lockhart, Nina Skuban, Jeff Castelli, Jay Barth, Carrolee Barlow, Raphael Schiffmann
Chronic kidney disease is a key risk factor for severe COVID-19: a call to action by the ERA-EDTA
Alberto Ortíz, Mario Cozzolino, Danilo Fliser, Denis Fouque, Dimitrios Goumenos, Ziad A. Massy, Alexander R. Rosenkranz, Ivan Rychlík, María José Soler, Kate Stevens, Roser Torrá, Serhan Tuğlular, Christoph Wanner, Ron T. Gansevoort, ERACODA Working Group, Raphaël Duivenvoorden, Casper Franssen, Marc H. Hemmelder, Luuk B. Hilbrands, Kitty J. Jager, Marlies Noordzij, Priya Vart, Ron T Gansevoort